Home News & Views

News & Views

FILTER:

Telix Pharmaceuticals and Atlab Pharma Conclude Therapeutic Product Development Agreement for Prostate Cancer

Telix is pleased to announce the completion of a product collaboration and purchase option agreement with Atlab Pharma SAS (Atlab).
Read more

Telix Pharmaceuticals Acquires Glioblastoma Program from Therapeia

Telix is pleased to announce a product development partnership with Therapeia GmbH & Co KG (“Therapeia”).
Read more

Wilex Signs Antibody License Agreement With Telix Pharmaceuticals Limited

Telix is delighted to have established this licensing agreement with Wilex for an important product with the potential to significantly impact cancer care.
Read more